News

Dr. David Wright Secures CIHR Grant for Novel Antipsychotic Side Effects Study

Dr. David Wright Secures CIHR Grant for Novel Antipsychotic Side Effects Study

Dr. David Wright, in partnership with Dr. Margaret Hahn from the University of Toronto, has secured a significant grant from the Canadian Institute of Health Research (CIHR) for their project titled “Targeting the Exercise-Inducible Signalling Factor FGF21 as a Novel Approach to Alleviate the Side Effects of Antipsychotics.” This initiative addresses a pressing need within […]